LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on May 11, 2026

Oxbridge Re Highlights Strong Q1 2026 Execution, Platform Growth and Market Opportunity
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oculis Reports Q1 2026 Financial Results and Provides Company Update
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
Inter Sets the Rule of 50 as the Company’s North Star
다크 호스 컨설팅 그룹 (Dark Horse Consulting Group)과 쿤퉈 (KunTuo), 중국 내 세포·유전자 치료제 임상 개발 가속화를 위한 양해각서 체결 발표
Dark Horse Consulting Group 与 KunTuo 宣布签署谅解备忘录,为细胞和基因疗法研发企业提供加速中国临床研发的途径
ダークホース・コンサルティング・グループと昆拓、細胞・遺伝子治療開発企業向けに中国での臨床開発を加速させる覚書の締結を発表
Dark Horse Consulting Group dan KunTuo Mengumumkan Memorandum Persefahaman bagi Menyediakan Laluan Dipercepatkan ke Arah Pembangunan Klinikal di China untuk Pembangun Terapi Sel dan Gen
Dark Horse Consulting Group 與 KunTuo 宣佈簽署諒解備忘錄,讓細胞與基因治療開發商能夠加快在中國臨床開發
Valeria Tamayo Announces Upcoming Book A Journey Back to You on Resilience and Personal Transformation
NexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
Pheast Therapeutics Presents Preclinical Data on PHST677, a Novel Bispecific ADC Targeting CDH1 and Nectin-4 at PEGS Boston Summit 2026
inCruises Reports Record Wave Season with Over 50,000 Passengers Booked
inCruises reporta temporada alta histórica con más de 50,000 pasajeros reservados
inCruises registra una Wave Season record con oltre 50.000 passeggeri confermati
Acoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failure
Aeries Technology Partners with Two Circles to Launch New Hyderabad Office
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.